FDA Approved: COBENFY — Original Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved COBENFY, a combination of xanomeline and trospium chloride, for the treatment of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• COBENFY (Xanomeline and Trospium Chloride)

Snippet

ORIG AP for COBENFY (XANOMELINE AND TROSPIUM CHLORIDE)